Evidence map›Paper›PMID 38398528›Full record

ReviewMolecules (Basel, Switzerland)2024

An Update of Kaempferol Protection against Brain Damage Induced by Ischemia-Reperfusion and by 3-Nitropropionic Acid.

Carmen López-Sánchez, Ricardo Lagoa, Joana Poejo, Virginio García-López, Virginio García-Martínez, Carlos Gutierrez-Merino

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Carmen López-SánchezInstitute of Molecular Pathology Biomarkers, University of Extremadura, 06006 Badajoz, Spain.ORCID 0000-0003-3296-2071
Ricardo LagoaSchool of Technology and Management, Polytechnic Institute of Leiria, Morro do Lena-Alto do Vieiro, 2411-901 Leiria, Portugal.ORCID 0000-0003-2375-6612
Joana PoejoInstitute of Molecular Pathology Biomarkers, University of Extremadura, 06006 Badajoz, Spain.ORCID 0000-0001-8740-1074
Virginio García-LópezInstitute of Molecular Pathology Biomarkers, University of Extremadura, 06006 Badajoz, Spain.ORCID 0000-0003-1489-7296
Virginio García-MartínezInstitute of Molecular Pathology Biomarkers, University of Extremadura, 06006 Badajoz, Spain.ORCID 0000-0002-7760-1985
Carlos Gutierrez-MerinoInstitute of Molecular Pathology Biomarkers, University of Extremadura, 06006 Badajoz, Spain.ORCID 0000-0003-3673-7007
Universidad de Extremadura · ESInstituto Politécnico de Leiria · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kaempferol, a flavonoid present in many food products, has chemical and cellular antioxidant properties that are beneficial for protection against the oxidative stress caused by reactive oxygen and nitrogen species. Kaempferol administration to model experimental animals can provide extensive protection against brain damage of the

Indexed as

Brain InjuriesIschemic StrokeNeuroprotective AgentsNitro CompoundsPropionatesStrokeAnimalsBrainIschemiaKaempferolsOxidative StressReperfusion3-nitropropionic acidKaempferolsNeuroprotective AgentsNitro CompoundsPropionates3-nitropropionic acidbrain neurodegenerationbrain strokeflavonoidsHuntington’s diseaseischemia reperfusionkaempferolpharmacological implications

Identifiers

PMID38398528
PMCPMC10893315
OpenAlexW4391647344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.